ABBV-706
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ABBV-706, covering 2025-10-20 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer [Phase 2]